| Chr | chr7 |
| start | 27184518 |
| end | 27189293 |
| lncRNA name | HOXA11-AS |
| entrez id | 221883 |
| hgnc id | HGNC:24957 |
| ensg id | ENSG00000240990 |
| refseq id | NR_002795 |
| methods | qPCR etc. |
| regulated | up-regulated |
| function description | The data revealed that the relative transcript level of HOXA11-AS was upregulated in vivo and in vitro in models of breast cancer. Knockdown of HOXA11-AS in MDA-MB-231 and MDA-MB-436 breast cancer cell lines inhibited the formation of cell colonies and arrested the cell cycle at the G0/G1 phase. Depletion of HOXA11-AS using two specific short interfering (si)RNAs against HOXA11-AS (siHOXA11-AS-1 and siHOXA11-AS-2) additionally suppressed the cell proliferative rate. Furthermore, transwell assays and wound-healing analysis revealed that siRNA transfection inhibited cell migration and invasion by ~50% in the two cell lines. The results of the present study demonstrated the oncogenic role of HOXA11-AS in breast cancer, providing novel clues for the future clinical diagnosis and treatment of early stage breast cancer patients. |
| pubmed id | 28791375 |
| year | 2017 |
| title | Long non-coding RNA HOXA11-AS promotes cell proliferation and metastasis in human breast cancer |
| drug | X |
| circulating | X |
| survival | X |
CopyRight © University of Miami, USA; Harbin Medical University, China